ANDREA KELLER: Open Payments
NPI 1740594928 · ANNANDALE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,212 in 22 payments from 5 companies in 2025. Trend: 2023 $5,629 · 2024 $15,152 · 2025 $7,212
Speaker / faculty: $3,805Travel & lodging: $2,512Food & beverage: $644Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $6,874 |
| GlaxoSmithKline, LLC. | 1 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| ORPHALAN INC | 1 | $20 |
Products named: Livdelzi, Epclusa, XIFAXAN, IQIRVO, CUVRIOR.
Industry payments across VA — which companies pay providers there.
